RCT Study to Validate niPGT-A Clinical Benefit.

Phase

TERMINATED

Status

296

Enrollment

INDUSTRY

Sponsor class

Stopped The recruitment was halted on Mar 1st 2024, after the Data Monitoring Committee, due to low recruitment speed and sustained high dropout rate. Other elements impacted negatively, including the SARS-COV-2 pandemic or the inability to include new sites

Conditions

Aneuploidy
Chromosome Abnormality
Infertility

Interventions

DIAGNOSTIC_TEST: niPGT-A
OTHER: Morphology criteria

Sponsor

Igenomix